NASH PATHway to Treatment

January 6, 2023


Thank you for joining us for the Chronic Liver Disease Foundation's NASH PATHway to Treatment symposium. 

Please select “Register/Take Course” to complete the following:

  • Pre-Test
  • Post-Test
  • Program Evaluation

Upon completion, you will receive your accreditation certificate. 

The pre-test will close on Friday, January 6, at 3:00 PM MT.
The post-program activities will become available on Friday, January 6, at 4:00 PM MT.

Target Audience

This activity has been designed to meet the educational needs of gastroenterologists, hepatologists, nurse practitioners (NPs), physician assistants (PAs), and other healthcare professionals who are currently managing and treating patients with nonalcoholic steatohepatitis (NASH).

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Describe the pathophysiology, risk factors, clinical consequences and guidelines for diagnosis and treatment of NAFLD/NASH, highlighting that the presence of fibrosis is the most important independent predictor of clinical outcomes
  • Identify the most relevant advances and challenges in the diagnosis and treatment of NASH and liver fibrosis and discuss the latest NASH screening guidelines
  • Discuss novel agents in development for the treatment of NASH, highlighting the diversity in molecular targets, proposed mechanism of actions and available evidence of the safety and efficacy
Course summary
Available credit: 
  • 1.25 AMA PRA Category 1 Credit
  • 1.25 AMA PRA Category 1 Credit™ (Non- MD)
Course opens: 
Course expires: 
Event starts: 
01/06/2023 - 4:45pm EST
Event ends: 
01/06/2023 - 6:00pm EST
In support of improving patient care, this activity has been planned and implemented by Medical Education Resources (MER) and Chronic Liver Disease Foundation (CLDF). MER is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Credit

Medical Education Resources designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Relevant Financial Relationships

It is the policy of Medical Education Resources to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. In accordance with this policy, MER identifies relevant financial relationships with its instructors, content managers, and other individuals who are in a position to control the content of an activity. Conflicts are mitigated by MER to ensure that all scientific research referred to, reported, or used in a continuing education activity conforms to the generally accepted standards of experimental design, data collection, and analysis.

This activity is jointly provided by Medical Education Resources and the Chronic Liver Disease Foundation.

Supported by an educational grant from Novo Nordisk Inc.

Available Credit

  • 1.25 AMA PRA Category 1 Credit
  • 1.25 AMA PRA Category 1 Credit™ (Non- MD)
Please login or register to take this course.